FDA — authorised 31 December 1979
- Application: NDA017874
- Marketing authorisation holder: BAXTER HLTHCARE CORP
- Local brand name: TRANSDERM SCOP
- Indication: SYSTEM — TRANSDERMAL
- Status: approved
FDA authorised Transderm Scop® on 31 December 1979
Yes. FDA authorised it on 31 December 1979.
BAXTER HLTHCARE CORP holds the US marketing authorisation.